Global Prefilled Syringes Market Research Report: Information by Material (Glass Prefilled Syringes, Oil Siliconized Syringes, Baked on Silicone Syringes and Plastic Syringes), Type (Conventional Prefilled Syringes and Safety Prefilled Syringes), Design (Single-Chamber Prefilled Syringes, Dual-Chamber Prefilled Syringes and Customized Prefilled Syringes), End User (Hospitals/Clinics and Ambulatory Surgical Center) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2024
ID: MRFR/MED/4708-CR | August 2019 | Region: Global | 157 pages
Prefilled syringes are disposable syringes that are already filled with the pharmaceutical substances that are to be injected into the body. These syringes ensure that injections reach the appropriately penetrated and that dosages are administered smoothly. Prefilled syringes have come to be the fastest-growing segment of the injectable drug delivery devices market. The growth of prefilled syringes over other forms of drug delivery systems can be attributed to its ease of administration, improved safety, reduced risk of contamination, accurate dosing, and high prevalence of chronic diseases.
Market Dynamics
Chronic diseases are diseases that persist for a long time and require the frequent administration of drugs. The increase in chronic diseases is likely to enhance the growth of the prefilled syringes market as parenteral drug delivery is the second most preferred route of administration. According to the World Health Organization, in 2017, the global prevalence of diabetes among adults aged 18 years or more was estimated to be about 8.5% in 2014. Additionally, according to the National Cancer Institute, in 2016, an estimated 1,685,210 new cases of cancer were diagnosed in the US, and about 595,690 people died from the disease. Similarly, according to a study published in the Asian Pacific Journal of Tropical Biomedicine, in 2014, it was estimated that about 150 million diabetic patients reside within the region, of which more than 95% have type 2 diabetes mellitus. This rise in diabetes, cancer, and cardiovascular disorders is likely to drive the growth of the global prefilled syringes market.
Global Prefilled Syringes Market Share, by Design, 2017 (%)
Source: MRFR Analysis
Segmentation
The global prefilled syringes market, based on material, has been divided into glass prefilled syringes and plastic syringes. The glass prefilled syringes segmented is further sub-segmented into oil siliconized syringes and baked on silicone syringes.
Based on type, the global market is divided into conventional prefilled syringes and safety prefilled syringes.
Based on design, the global prefilled syringes market is segmented into single-chamber prefilled syringes, dual-chamber prefilled syringes, and customized prefilled syringes.
Based on end user, the global prefilled syringes market has been divided into hospitals/clinics and ambulatory surgical center.
Global Prefilled Syringes Market Share, by Region, 2017 (%)
Source: MRFR Analysis
Regional Analysis
The global prefilled syringes market, based on region, is segmented into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.
Europe accounted for the largest market share of about 41.4% in 2017 and is estimated to dominate the prefilled syringes market during the forecast period. The larger share is primarily attributed to the growing geriatric population, demand for quality healthcare, increasing trend of home-based treatment coupled with high healthcare expenditure. The Americas accounted for the second-largest market share, whereas Asia-Pacific is expected to grow at the fastest growth rate of about 10.78% during the forecast period. With lots of opportunities and continuously growing economies, the region is expected to be the fastest-growing region. Additionally, factors such as Japan’s rapid adoption of plastic devices along with the recent healthcare developments and the increasing number of public and private hospitals, are influencing the growth of the market. The Middle East & Africa with less economic developments and extremely low-income accounted for the least market share in 2017 but is expected to grow steadily during the forecast period.
Key Players
The prominent players in the global prefilled syringes market are Gerresheimer AG, Schott AG, Medtronic, TERUMO CORPORATION, Abbott, Nipro Corporation, Baxter, Becton, Dickinson and Company, West Pharmaceutical, Weigao Group, Vetter Pharma International GmbH, and OMPI (A Stevanato Group Company).
Some of the key strategies followed by players operating in the global prefilled syringes market were innovation, product development, and acquisition & mergers.
- In April 2018, Schott launched syriQ BioPure, a pre-fillable glass syringe for the biologics market. This glass syringe aims to keep the drugs stable over the shelf life and makes administration more convenient for patients
- In January 2017, Terumo signed an agreement with Nemera, the manufacturer of drug delivery solutions to combine Plajex, a polymer-based Pre-Filled Syringe (PFS) with Safe’n’Sound
- In December 2017, Becton, Dickinson and Company acquired C. R. Bard, Inc., a medical technology company offering diagnostics and therapeutics
Market Segmentation
Global Prefilled Syringes Market, by Material
- Glass Prefilled Syringes
- Oil Siliconised Syringes
- Baked-On Silicone Syringes
- Plastic Syringes
Global Prefilled Syringes Market, by Type
- Conventional Prefilled Syringes
- Safety Prefilled Syringes
Global Prefilled Syringes Market, by Design
- Single-Chamber Prefilled Syringes
- Dual-Chamber Prefilled Syringes
- Customized Prefilled Syringes
Global Prefilled Syringes Market, by End User
- Hospitals/Clinics
- Ambulatory Surgical Center
Global Prefilled Syringes Market, by Region
- Americas
- North America
- US
- Canada
- Europe
- Western America
- Germany
- France
- UK
- Italy
- Spain
- Rest of Western Europe
- Eastern Europe
- Western America
- Asia-Pacific
- China
- Japan
- Australia
- South Korea
- India
- Rest of Asia Pacific
- Middle East & Africa
- Middle East
- Africa
Additional Customizations
- Upcoming Technologies and Trends
- Pricing Analysis
Intended Audience
- Clinical laboratories
- Pharmaceutical & MedTech companies
- Government organizations
- Research & consulting firms
- Biotechnology companies
Frequently Asked Questions (FAQ) :
Prefilled Syringes Market is predicted to touch USD 8397.23 million by 2024.
Prefilled Syringes Market is projected to grow at a 10.20% CAGR between 2015-2024.
Europe is projected to dominate the Prefilled Syringes Market.
Top players profiled in the Prefilled Syringes Market include OMPI (A Stevanato Group Company), Vetter Pharma International GmbH, Weigao Group, West Pharmaceutical, Dickinson and Company, Becton, Baxter, Nipro Corporation, Abbott, TERUMO CORPORATION, Medtronic, Schott AG, and Gerresheimer AG.
Rising prevalence of chronic diseases and ease of administration are boosting market growth.
